Clinical Science & Medical Affairs
Associate Director – Executive Director, Clinical Science & Medical Affairs
Clinical-science and medical-affairs lead for the global Phase 3 AVTA30-01 head and neck cancer program, with responsibility across glioblastoma, oral dysplasia and emerging development programs.

